Utilizing baseline multiregional MRI radiomics for prediction of tumor deposition and prognosis following neoadjuvant therapy in resectable rectal cancer

Colorectal cancer (CRC) is one of the most common cancers worldwide, with its incidence and mortality rates ranking the third and second among all malignant tumors in the world [1]. Epidemiological data indicate that distant recurrence constitutes the primary cause of mortality in rectal cancer cases [2]. Therefore, precise risk stratification for recurrence is crucial for enhancing survival outcomes. Tumor deposit (TD) refers to a nodule devoid of identifiable lymph node tissue or vascular/neur…

Read the full article on ejradiology.com